Sign in
4

Changes in Ownership

Dianthus Therapeutics, Inc. /DE/ Filed Acc 0000899243-22-018804

Options or other derivatives

  • See Remarks acquired 62,500 shares (grant or award)

From the SEC's structured data for this filing

Trades in this filing

Insider Date Transaction Shares Price Value Owned after D/I
Derivatives
Mahoney Stephen F. See Remarks 2022-05-17 Grant or award · Stock Option (Right to Buy) +62,500 62,500 D
Loading xslF345X03/doc4.xml…